CAS 1956366-10-1

1H-Pyrrole-2-carboxamide, 4-[5-chloro-2-[(1-methylethyl)amino]-4-pyridinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-, hydrochloride (1:1)

Description:

1H-Pyrrole-2-carboxamide, 4-[5-chloro-2-[(1-methylethyl)amino]-4-pyridinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-, hydrochloride (1:1), identified by CAS number 1956366-10-1, is a synthetic organic compound characterized by its complex molecular structure, which includes a pyrrole ring and various functional groups such as amines and hydroxyls. This compound typically exhibits properties associated with its heterocyclic structure, including potential biological activity, making it of interest in pharmaceutical research. The presence of chlorine substituents may influence its reactivity and interaction with biological targets. As a hydrochloride salt, it is likely to be more soluble in water compared to its free base form, enhancing its bioavailability. The compound's stereochemistry, indicated by the (1S) configuration, suggests specific spatial arrangements that can affect its pharmacological properties. Overall, this compound's unique characteristics make it a candidate for further investigation in medicinal chemistry and drug development.

Formula: C₂₁H₂₂Cl₂N₄O₂·ClH

InChI: InChI=1S/C21H22Cl2N4O2.ClH/c1-12(2)26-20-8-16(17(23)10-25-20)14-7-18(24-9-14)21(29)27-19(11-28)13-4-3-5-15(22)6-13;/h3-10,12,19,24,28H,11H2,1-2H3,(H,25,26)(H,27,29);1H/t19-;/m1./s1

InChI key: InChIKey=DKGYQCPFBWFTHM-FSRHSHDFSA-N

SMILES: ClC1=C(C=2C=C(C(N[C@H](CO)C3=CC(Cl)=CC=C3)=O)NC2)C=C(NC(C)C)N=C1.Cl

Synonyms:

• 1H-Pyrrole-2-carboxamide, 4-[5-chloro-2-[(1-methylethyl)amino]-4-pyridinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-, hydrochloride (1:1)

Ulixertinib hydrochloride

CAS: 1956366-10-1

Formula: C₂₁H₂₃Cl₃N₄O₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 469.7919

Ref: IN-DA01EN3G

Ulixertinib hydrochloride

CAS: 1956366-10-1

Ulixertinib hydrochloride

Purity: ≥98%

Molecular weight: 469.79g/mol

Ref: 54-BUP05695

Ulixertinib hydrochloride

CAS: 1956366-10-1

Ulixertinib hydrochloride

Purity: 98%

Molecular weight: 469.79g/mol

Ref: 54-BISN0233

Ulixertinib hydrochloride

CAS: 1956366-10-1

Ulixertinib hydrochloride (Ulixertinib HCl) is an ERK1/2 inhibitor with anticancer and antitumor activity that inhibits the NB cell cycle and promotes apoptosis

Formula: C₂₁H₂₃Cl₃N₄O₂

Purity: 99.85%

Color and Shape: Solid

Molecular weight: 469.79

Ref: TM-T7005L

Ulixertinib Hydrochloride

Controlled Product

CAS: 1956366-10-1

Formula: C₂₁H₂₂Cl₂N₄O₂(HCl)

Color and Shape: Neat

Molecular weight: 433.333646

Ref: TR-U700835

Ulixertinib hydrochloride

CAS: 1956366-10-1

Ulixertinib is an investigational drug, which is an inhibitor of the receptor tyrosine kinase MET. Ulixertinib has been shown to inhibit the proliferation of cancer cells and induce tumor regression in a xenograft model of human lung adenocarcinoma. It also inhibits the growth of cancer cells by blocking cell cycle progression at G2/M phase and inducing apoptosis. Ulixertinib inhibits MET-mediated phosphorylation of downstream signaling molecules that regulate cell survival, proliferation, motility, angiogenesis, and metastasis. Ulixertinib hydrochloride is a high purity product with a purity level > 98%.

Formula: C₂₁H₂₃Cl₃N₄O₂

Purity: Min. 95%

Molecular weight: 469.79 g/mol

Ref: 3D-GDD36610